Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations

被引：0

作者：

Jinghua He

Christopher D. Pericone

Julie Vanderpoel

机构：

[1] Janssen Scientific Affairs,

[2] LLC,undefined

来源：

Advances in Therapy | 2022年 / 39卷

关键词：

Biomarker testing; mutations; Exon 20 mutations; Immunotherapy; Next-generation sequencing; NSCLC; Treatment pathways; Tyrosine kinase inhibitors;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：3347 / 3360

页数：13

共 50 条

[21] EGFR Mutation Testing Practice in Advanced Non-Small Cell Lung Cancer [J].

Jair Bar ;

Arnold Cyjon ;

Dov Flex ;

Hadas Sorotsky ;

Haim Biran ;

Julia Dudnik ;

Nili Peylan-Ramu ;

Nir Peled ;

Hovav Nechushtan ;

Maya Gips ;

Rivka Katsnelson ;

Shoshana Keren Rosenberg ;

Ofer Merimsky ;

Amir Onn ;

Maya Gottfried .

Lung, 2014, 192 :759-763

[22] Retrospective Analysis of Real-World Treatment Patterns and Survival Outcomes for Non-small Cell Lung Cancer Patients in Thailand [J].

Supaattagorn, S. ;

Maneenil, K. .

JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) :S603-S604

[23] Treatment Patterns, Clinical Outcomes and Healthcare Costs of Advanced Non-Small Cell Lung Cancer: A Real-World Evaluation in Italy [J].

Franchi, Matteo ;

Cortinovis, Diego ;

Corrao, Giovanni .

CANCERS, 2021, 13 (15)

[24] Real-World Biomarker Testing and Treatment Patterns Identified Using Machine Learning in Early Non-small Cell Lung Cancer [J].

Lee, J. M. ;

Schulze, K. ;

Nedzesky, J. ;

Ng, C. ;

Ogale, S. ;

Johnson, A. ;

Hasan, H. ;

Secrest, M. H. ;

Cohen, A. ;

Castellanos, E. ;

Estola, E. ;

Estevez, M. ;

Lee, J. S. .

JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) :S555-S556

[25] Bevacizumab to combat EGFR-TKI resistance in a patient with advanced non-small cell lung cancer harboring an EGFR mutation: A case report [J].

Wang, Zhiyi ;

Zhou, Pu ;

Li, Guanghui .

ONCOLOGY LETTERS, 2016, 12 (01) :356-360

[26] Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer [J].

Igawa, Satoshi ;

Ono, Taihei ;

Kasajima, Masashi ;

Kusuhara, Seiichiro ;

Otani, Sakiko ;

Fukui, Tomoya ;

Yokoba, Masanori ;

Kubota, Masaru ;

Katagiri, Masato ;

Mitsufuji, Hisashi ;

Sasaki, Jiichiro ;

Naoki, Katsuhiko .

INVESTIGATIONAL NEW DRUGS, 2020, 38 (06) :1906-1914

[27] Real-world patterns of biomarker testing and targeted therapy in de novo metastatic non-small cell lung cancer patients in the US oncology network [J].

Nadler, Eric ;

Vasudevan, Anupama ;

Wang, Yunfei ;

Ogale, Sarika .

CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 31

[28] Uncommon EGFR mutations in advanced non-small cell lung cancer [J].

O'Kane, Grainne M. ;

Bradbury, Penelope A. ;

Feld, Ronald ;

Leighl, Natasha B. ;

Liu, Geoffrey ;

Pisters, Katherine -M. ;

Kamel-Reid, Suzanne ;

Tsao, Ming S. ;

Shepherd, Frances A. .

LUNG CANCER, 2017, 109 :137-144

[29] Real-World Outcomes Among Advanced Non-Small Cell Lung Cancer Patients Re-Treated with Immunotherapy in the US [J].

Spira, A. ;

Monnette, A. ;

Wentworth, C. ;

Doan, J. ;

Chang, C. ;

Hartman, J. .

JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) :S189-S190

[30] Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than EGFR : a multicenter real-world analysis [J].

Tian, Tian ;

Li, Yanying ;

Li, Juan ;

Xu, Hongyu ;

Fan, Hua ;

Zhu, Jiang ;

Wang, Yongsheng ;

Peng, Feng ;

Gong, Youling ;

Du, Yijia ;

Yan, Xiaoyan ;

He, Xiulan ;

Daylan, Ayse Ece Cali ;

Pircher, Andreas ;

Neibart, Shane S. ;

Okuma, Yusuke ;

Hong, Min Hee ;

Huang, Meijuan ;

Lu, You .

TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (04) :861-874

← 1 2 3 4 5 →